Risk of Ischemic Heart Disease in Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study

Abstract

Background Subjects with chronic obstructive pulmonary disease (COPD) have a higher risk of ischemic heart disease (IHD) than individuals without COPD; however, longitudinal evidence is lacking. Therefore, we aimed to estimate the risk of IHD between COPD and control cohorts using a longitudinal nationwide database. Methods We used 2009–2017 data from the Korean National Health Insurance Service National Sample Cohort (NHIS-NSC). Adult participants at least 20 years of age who underwent health examinations and without a history of COPD or IHD were included (n = 540,976). Participants were followed from January 1, 2009, until death, development of IHD, or December 31, 2019, whichever came first. Results At baseline, there were 3,421 participants with incident COPD and 537,555 participants without COPD. During a median of 8.0 years (5.3–9.1 years) of follow-up, 2.51% of the participants with COPD (n = 86) and 0.77% of the participants without COPD (n = 4,128) developed IHD, with an incidence of 52.24 and 10.91 per 10,000 person-years, respectively. Participants with COPD had a higher risk of IHD (adjusted hazard ratio, 1.55; 95% confidence interval, 1.25–1.93) than subjects without COPD. Demographics such as age, sex, body mass index, and personal health behaviors including smoking status and physical activity did not show significant interaction with the relationship between COPD and IHD ( P for interaction > 0.05 for all). Conclusion The results indicate that COPD is associated with the development of IHD independent of demographic characteristics and health-related behaviors. Based on these results, clinicians should closely monitor the onset of IHD in subjects with COPD.

Tuberculosis and osteoporotic fracture risk: development of individualized fracture risk estimation prediction model using a nationwide cohort study

“…Socioeconomic position (location of residence and level of income), lifestyle factors (smoking, alcohol consumption, and physical activity), and BMI were considered potential covariates ( 24 – 32 ). Smoking status was categorized into three groups: never, former, and current smokers.…”

Increased Risk of Incident Chronic Obstructive Pulmonary Disease and Related Hospitalizations in Tuberculosis Survivors: A Population-Based Matched Cohort Study

“…Comorbidities (hypertension, diabetes mellitus [DM], dyslipidemia, chronic kidney disease, ischemic heart disease, asthma, bronchiectasis, and cancer) were defined based on a combination of past medical history, ICD-10 codes, or drug prescriptions (for DM, dyslipidemia, or hypertension). 22 23 24 25 26 The Charlson comorbidity index was calculated based on the ICD-10 codes and used to classify study participants into 4 groups (0, 1, 2, or ≥ 3 points). 27 Data regarding physical examinations and laboratory findings were derived from the health screening records maintained by the NHIS.…”

Risk of newly diagnosed interstitial lung disease after COVID-19 and impact of vaccination: a nationwide population-based cohort study

“…This was a retrospective cohort study using the Korean National Health Insurance claims-based dataset. The National Health Insurance Service (NHIS) is the universal insurance provider in Korea that is managed by the government and covers 97% of the Korean population (~50 million people) ( 11 , 12 ). During the COVID-19 pandemic, the Korean government encouraged people to get tested for COVID-19 without delay by subsidizing the cost of diagnosis and treatment for individuals who met criteria related to COVID-19 and provided health insurance services to all Koreans with COVID-19 (NHIS-2022-1-623) ( 13 ).…”

“…Using ICD-10 codes, the comorbidities of hypertension (I10-13, and I15), diabetes mellitus (DM, E10-14), chronic kidney disease (CKD, N18), allergic rhinitis (J30), and/or dyslipidemia (E78) with at least one diagnosis within 1 year were also recorded (12,(19)(20)(21)(22)(23)(24)(25)(26).…”